参考文献/References:
[1] CHEN Yongpeng, HUANG Liwen, LIN Xiaoyu, et al. Alanine aminotransferase influencing performances of routine available tests detecting hepatitis B-related cirrhosis[J]. Journal of Viral Hepatitis, 2020, 27(8): 826-836.
[2] CHOI S H, KIM B T, SHIN J, et al. Combined effect of serum alanine aminotransferase and gammaglutamyltransferase on incidence of diabetes mellitus: A longitudinal study [J]. Medicine, 2020, 99(11): e18963.
[3] ZOU Yang, ZHONG Ling, HU Chong, et al. Association between the alanine aminotransferase/ aspartate aminotransferase ratio and new-onset nonalcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study[J]. Lipids in Health and Disease, 2020, 19(1): 245.
[4] 薛丽, 黄芳, 张彦平, 等. 丙肝患者血清HCV-RNA 含量与肝功能及血常规指标的相关性[J]. 现代检验 医学杂志, 2017, 32(5):110-114. XUE Li, HUANG Fang, ZHANG Yanping, et al. Relevance of serum HCV-RNA level with routine liver function indices and blood routine parameters in patients with hepatitis C[J].Journal of Modern Laboratory Medicine, 2017, 32(5):110-114.
[5] SIRCAR K, HEWLETT B R, HUIZINGA J D, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors[J]. The American Journal of Surgical Pathology, 1999, 23(4): 377-389.
[6] JOENSUU H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J]. Human Pathology, 2008, 39(10): 1411-1419.
[7] 朱文芳, 沈建军, 付涛, 等.血清GPDA 联合肿瘤 标志物对胃癌早期诊断的临床价值[J]. 现代检验医 学杂志, 2017,32(4):110-112. ZHU Wenfang, SHEN Jianjun, FU Tao, et al. Clinical value of serum GPDA associated tumor markers for early diagnosis of gastric cancer [J]. Journal of Modern Laboratory Medicine, 2017,32(4):110-112.
[8] 乔新民, 王丽君.血清CYFRA21-1,CA125,CA19-9 水平联合检测在胃癌诊断中的价值[J].现代检验医 学杂志, 2020, 35(1):90-93. QIAO Xinmin, WANG Lijun. Value of combined detection of serum CYFRA21-1, CA125 and CA19-9 levels in the diagnosis of gastric cancer [J]. Journal of Modern Laboratory Medicine, 2020, 35(1):90-93.
[9] 卓传尚, 柳丽娟, 周淑燕.AFP-L3 和PIVKA- Ⅱ检 测对高危人群良恶性肝病的鉴别诊断价值[J]. 现代 检验医学杂志, 2017, 32(4):40-42, 46. ZHUO Chuanshang, LIU Lijuan, ZHOU Shuyan. Performance of serum AFP-L3 and PIVKA- Ⅱ in differential diagnosis of benign and malignant liver disease in high risk population [J]. Journal of Modern Laboratory Medicine, 2017, 32 (4): 40-42,46.
[10] 王军, 张文胜, 裴效瑞, 等. 胃肠道间质瘤临床诊 断与治疗研究进展[J]. 中国肿瘤临床与康复, 2019, 26(1):122-124. WANG Jun, ZHANG Wensheng, PEI Xiaorui, et al. Progress in clinical diagnosis and treatment of gastrointestinal stromal tumor [J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2019, 26(1):122- 124.
[11] SCHEIPNER L, SMOLLE M A, BARTH D, et al. The AST/ALT ratio is an independent prognostic marker for disease-free survival in stage II and III colorectal carcinoma[J]. Anticancer Research, 2021, 41(1): 429-436.
[12] LIU Xu, MENG Jing, XU Hongqin, et al. Alphafetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma[J]. Medicine (Baltimore), 2019 ,98(17):e15414.
[13] DURHAN A, SENLIKCI A, KOSMAZ K, et al. An evaluation of the effect of preoperative inflammationbased factors on survival in gastric cancer patients[J]. Journal of the College of Physicians and Surgeons- Pakistan, 2021, 31(3): 282-287.
[14] 赵杰, 余海波, 朱运海, 等.肝癌根治术前GGT, ALT/AST 和术后临床病理特征与预后的关系[J]. 中 华普通外科杂志, 2019, 34(4):328-331. ZHAO Jie, YU Haibo, ZHU Yunhai, et al. Preoperative GGT, ALT/AST relates to clinicopathological features and prognosis after radical surgery for hepatocellular carcinoma [J]. Chinese Journal of General Surgery, 2019, 34(4):328-331.
[15] 王姗.血清GGT 和AST/ALT 对原发性肝癌预后的 评估价值[J].临床肝胆病杂志, 2019, 35(10):2334. WANG Shan. Prognostic value of serum GGT and AST / ALT in patients with primary liver cancer [J]. Journal of Clinical Hepatology, 2019, 35(10):2334.
[16] RIEDL J M, POSCH F, PRAGER G, et al. The AST/ ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study[J]. Ther Adv Med Oncol, 2020,12:1758835919900872.
[17] ZHOU Jiatong, HE Zhaowei, MA Shenfei, et al. AST/ ALT ratio as a significant predictor of the incidence risk of prostate cancer[J]. Cancer Medicine, 2020, 9(15): 5672-5677.
[18] GORGEL S N, KOSE O, KOC E M, et al. The prognostic significance of preoperatively assessed AST/ ALT (De Ritis) ratio on survival in patients underwent radical cystectomy[J]. International Urology and Nephrology, 2017, 49(9): 1577-1583.
[19] HUANG Hao, WANG Xueping, LI Xiaohui, et al. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/ AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma[J]. BMC Cancer, 2017, 17(1): 544.
[20] 吴佳, 李钟声, 姚寒晖.胃癌患者术前血清丙氨酸氨 基转移酶及天冬氨酸氨基转移酶比值与其预后的关 联[J]. 中华全科医学, 2020, 18(11):1854-1856,1932. WU Jia, LI Zhongsheng, YAO Hanhui. Association of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio and prognosis in patients with gastric cancer [J]. Chinese Journal of General Practice, 2020, 18(11):1854-1856,1932.
[21] 韩帮岭, 汪亦民, 薛英威.术前血清丙氨酸氨基转 移酶与天冬氨酸氨基转移酶比值对胃癌患者预后的 影响[J].中华胃肠外科杂志, 2020,23(1):65-70. HAN Bangling, WANG Yimin, XUE Yingwei. Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer [J]. Chinese Journal of Gastrointestinal Surgery, 2020,23(1):65-70.
[22] GAITANIDIS A, EL LAKIS M, ALEVIZAKOS M, et al. Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs)[J]. Langenbeck’s Archives of Surgery, 2018, 403(5): 599- 606.
[23] 郑瑞, 庞涛, 张新, 等.139 例胃肠道间质瘤患者临 床疗效及预后分析[J]. 中华保健医学杂志, 2019, 21(4):338-340. ZHENG Rui, PANG Tao, ZHANG Xin, et al. Clinical efficacy and prognosis of 139 patients with gastric stromal tumor [J]. Chinese Journal of Health Care and Medicine, 2019, 21(4):338-340.
相似文献/References:
[1]穆润清,田 文.辽宁地区成年体检人群ALT,AST季节性变异的研究[J].现代检验医学杂志,2016,31(02):32.[doi:10.3969/j.issn.1671-7414.2016.02.010]
MU Run-qing,TIAN Wen.Study on the Seasonal Variation of Aminotransferase
for Population of Liaoning[J].Journal of Modern Laboratory Medicine,2016,31(02):32.[doi:10.3969/j.issn.1671-7414.2016.02.010]
[2]郭 燕,贺 晨,段 勇,等.无偿献血者ALT 水平异常与HBI,OBI,HCI 和OCI 的相关性研究[J].现代检验医学杂志,2020,35(02):18.[doi:10.3969/j.issn.1671-7414.2020.02.006]
GUO Yan,HE Chen,DUAN Yong,et al.Investigating the Correlation of Abnormal ALT Level andHBI, OBI, HCI, OCI in Volunteer Blood Donors[J].Journal of Modern Laboratory Medicine,2020,35(02):18.[doi:10.3969/j.issn.1671-7414.2020.02.006]
[3]刘振国a,王婷b,卢晓娥a.CVVHDF联合HP治疗蜂蜇伤患者临床生化指标的变化研究[J].现代检验医学杂志,2015,30(05):115.[doi:10.3969/j.issn.1671-7414.2015.05.035]
LIU Zhen-guoa,WANG Tingb,LU Xiao-ea.Analysis of the Changes of Clinical and Biochemical Indexes
in Treatment of Continuous Venovenous Hemodiafiltration Combined
with Hemoperfusion in Patients with Bee Stings[J].Journal of Modern Laboratory Medicine,2015,30(02):115.[doi:10.3969/j.issn.1671-7414.2015.05.035]